Secondary gastrointestinal cancer in childhood cancer survivors: A cohort study

Annals of Internal Medicine

Volumn 156, Issue 11, 2012, Pages 757-766

  Henderson, Tara O ^a   Oeffinger, Kevin C ^b   Whitton, John ^c   Leisenring, Wendy ^c   Neglia, Joseph ^d   Meadows, Anna ^e   Crotty, Catherine ^a   Rubin, David T ^a   Diller, Lisa ^f   Inskip, Peter ^g   Smith, Susan A ^h   Stovall, Marilyn ^h   Constine, Louis S ⁱ   Hammond, Sue ^j   Armstrong, Greg T ^k   Robison, Leslie L ^k   Nathan, Paul C ^l  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^j NATIONWIDE CHILDREN S HOSPITAL   (United States)

^k ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^l HOSPITAL FOR SICK CHILDREN   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE; PROCARBAZINE; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; ANGIOSARCOMA; ANUS CANCER; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHILDHOOD CANCER; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG MEGADOSE; ESOPHAGUS CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTRINOMA; HEPATOBILIARY DISEASE; HODGKIN DISEASE; HUMAN; KLATSKIN TUMOR; LEIOMYOSARCOMA; LEUKEMIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PANCREAS ISLET CELL CARCINOMA; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMALL INTESTINE CANCER; SOFT TISSUE SARCOMA; STEM CELL TRANSPLANTATION; STOMACH CANCER; ADOLESCENT; CANADA; CHILD; COLORECTAL TUMOR; GASTROINTESTINAL TUMOR; HEALTH SURVEY; INCIDENCE; PATIENT EDUCATION; RADIOTHERAPY; SECOND CANCER; SURVIVOR; UNITED STATES;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CANADA; CHILD; COLORECTAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; NEOPLASMS, SECOND PRIMARY; PLATINUM COMPOUNDS; POPULATION SURVEILLANCE; PROCARBAZINE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84861912046     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-11-201206050-00002     Document Type: Article

References (28)

1. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102:1083-95. [PMID: 20634481]
2. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-29. [PMID: 11309438]
3. de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin MA, Schlienger JY, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999;79:1884-93. [PMID: 10206309]
4. Olsen JH, Möller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst. 2009;101:806-13. [PMID: 19470947]
5. Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, et al; British Childhood Cancer Survivor Study Steering Group. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA. 2011;305:2311-9. [PMID: 21642683]
6. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-72. [PMID: 11432882]
7. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, et al; Late Effects Study Group. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386-94. [PMID: 14645429]
8. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol. 2000;18:2435-43. [PMID: 10856104]
9. van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van't Veer MB, et al. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys. 2009;75:1420-9. [PMID: 19931732]
10. Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000;18: 498-509. [PMID: 10653865]
11. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20: 3484-94. [PMID: 12177110]
12. Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-96. [PMID: 12200357]
13. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors. The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979-90. [PMID: 15576413]
14. Children's Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer. Version 3.0. Arcadia, Canada: Children's Oncology Group; 2008. Accessed at www.survivorshipguidelines.org on 10 April 2012.
15. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-39. [PMID: 11920786]
16. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institutesupported resource for outcome and intervention research. J Clin Oncol. 2009; 27:2308-18. [PMID: 19364948]
17. Altekruse KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, et al, eds. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute; 2011.
18. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. New York: J Wiley; 1980: 168-9
19. Yasui Y, Liu Y, Neglia JP, Friedman DL, Bhatia S, Meadows AT, et al. A methodological issue in the analysis of second-primary cancer incidence in longterm survivors of childhood cancers. Am J Epidemiol. 2003;158:1108-13. [PMID: 14630607]
20. van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007; 25:4370-8. [PMID: 17906202]
21. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969;71:747-52. [PMID: 5360287]
22. Malkin D. Li-fraumeni syndrome. Genes Cancer. 2011;2:475-84. [PMID: 21779515]
23. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes [Letter]. J Med Genet. 2010;47:421-8. [PMID: 20522432]
24. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476-83. [PMID: 16421424]
25. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin. 2001; 51:38-75; quiz 77-80. [PMID: 11577479]
26. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2011;61:8-30. [PMID: 21205832]
27. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al; American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008. A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570-95. [PMID: 18384785]
28. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al; Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-60. [PMID: 12557158]